Hinge Health (NYSE:HNGE) President James Pursley Sells 16,000 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 16,000 shares of Hinge Health stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $53.79, for a total value of $860,640.00. Following the sale, the president directly owned 780,223 shares in the company, valued at $41,968,195.17. This trade represents a 2.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Monday, March 23rd, James Pursley sold 15,000 shares of Hinge Health stock. The shares were sold at an average price of $42.26, for a total value of $633,900.00.

Hinge Health Trading Up 1.0%

Shares of HNGE opened at $53.49 on Thursday. The business’s 50 day moving average is $45.61 and its 200 day moving average is $44.52. The company has a market capitalization of $4.14 billion and a PE ratio of -4.33. Hinge Health Inc. has a 12-month low of $30.08 and a 12-month high of $62.18.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.33. The company had revenue of $182.31 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The firm’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period last year, the business posted $1.30 EPS. Equities research analysts predict that Hinge Health Inc. will post 1.21 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HNGE. Citizens Jmp lifted their target price on Hinge Health from $65.00 to $80.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and issued a $45.00 price objective on shares of Hinge Health in a research note on Wednesday, April 8th. Zacks Research raised Hinge Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Stifel Nicolaus lifted their price objective on Hinge Health from $59.00 to $67.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $95.00 price objective on shares of Hinge Health in a research note on Wednesday, May 6th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $67.40.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in HNGE. Wells Fargo & Company MN boosted its holdings in shares of Hinge Health by 160.0% in the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after purchasing an additional 336 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in shares of Hinge Health in the 4th quarter worth approximately $26,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Hinge Health in the 3rd quarter worth approximately $37,000. CENTRAL TRUST Co purchased a new position in shares of Hinge Health in the 1st quarter worth approximately $37,000. Finally, First Horizon Corp boosted its holdings in shares of Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares during the period.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.